News | October 08, 2013

World Molecular Imaging Congress Features Scientific Breakthroughs in Molecular Multimodal Imaging

October 8, 2013 — The World Molecular Imaging Society (WMIS) held its sixth annual congress in Savannah, Ga. Sept. 18-21.  The World Molecular Imaging Congress (WMIC) 2013 featured advancements in molecular multimodal imaging with a focus on discovery, pre-clinical and translational research, highlighting first-in-human studies that drive innovative diagnostics and targeted therapy critical to the implementation of precision medicine.  

“Molecular imaging and targeted therapy are essential to the successful implementation of precision medicine,” said Hedvig Hricak M.D., Ph.D., chairman, radiology; Memorial Sloan-Kettering Cancer Center and one of eight plenary speakers at the WMIC 2013. “The WMIC is a unique international forum for discussing all aspects of molecular imaging research, from an idea to preclinical studies to first-in-human imaging trials. The WMIS is taking the lead in the global discussions of MI and its clinical applications and it is a pleasure and honor to take part in the 2013 WMIS annual meeting."

The program consisted of 168 oral presentations and 35 spotlight presentations emphasizing five categories: Chemistry and Imaging Probes, First-in-Human and Clinical Studies, Preclinical Cell and Tissue Level Studies, Preclinical In Vivo Studies and Technology and Software development.

For more information: www.wmicmeeting.org

Related Content

CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption
News | Nuclear Imaging | September 27, 2018
Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of...
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...
Abnormal Protein Concentrations Found in Brains of Military Personnel With Suspected CTE

Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.

News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...